Cargando…
Daratumumab in Patients With Bortezomib-Refractory Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits
Autores principales: | Almaani, Salem, Parikh, Samir V., Satoskar, Anjali A., Bumma, Naresh, Rovin, Brad H., Sharma, Nidhi, Efebera, Yvonne, Ayoub, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343787/ https://www.ncbi.nlm.nih.gov/pubmed/34386669 http://dx.doi.org/10.1016/j.ekir.2021.05.008 |
Ejemplares similares
-
Proliferative glomerulonephritis with monoclonal immunoglobulin in renal allografts
por: Al-Rabadi, Laith, et al.
Publicado: (2015) -
An update of proliferative glomerulonephritis with monoclonal immunoglobulin deposits
por: Li, Manna, et al.
Publicado: (2021) -
Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin Deposits
por: Zand, Ladan, et al.
Publicado: (2021) -
Membranoproliferative Glomerulonephritis With Changing Immunofluorescence Pattern
por: Satoskar, Anjali A., et al.
Publicado: (2022) -
Proliferative Glomerulonephritis with Monoclonal Immunoglobulins in a Child with Recurrence in the Allograft
por: Madireddy, Nishika, et al.
Publicado: (2023)